MedTrace Logo

Brief Transdiagnostic Group CBT for Adolescents With Internalizing Problems: A Randomized Waitlist Controlled Trial

NCT04716777 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-11-14

No results posted yet for this study

Summary

The investigators will evaluate a brief group-based cognitive-behavioral treatment program for adolescents aged 13-17 years with internalizing problems.

Conditions

Interventions

BEHAVIORAL

Brief Transdiagnostic group-based Cognitive-Behavioral Treatment

Weekly group-based transdiagnostic CBT sessions for eight weeks.

Sponsors & Collaborators

  • Primary Health Care Clinic, Reykjavik, Iceland

    collaborator UNKNOWN

  • University of Iceland

    lead OTHER

Principal Investigators

  • Gudmundur Skarphedinsson, PhD · University of Iceland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2023-01-20
Completion
2023-09-20

Countries

  • Iceland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04716777 on ClinicalTrials.gov